Preço da ação Vir Biotechnology (VIR) hoje, pré-mercado e after-hours

Dado

Supergráficos

Legend

Mais

Pesquisar

Vir Biotechnology, Inc.

VIR

Nasdaq

Health Technology

Biotechnology

8.80

USD

+0.11

+1.27%

Fechado: 07-27 20:00 (UTC+0)

8.80

USD

+0.00%

Pós-fechamento: 07-28 00:00 (UTC+0)

VIR Estatísticas principais

Alta

9.09

Abrir

8.82

Volume

1.68M

Baixa

8.77

Fechamento anterior

8.69

Valor negociado

14.99M

52 sem. máx.

11.66

Vol. relativo

1.022

Amplitude (%)

3.62%

52 sem. mín.

4.16

Taxa de giro

1.00%

Cap. de Mercado

1.46B

P/L (TTM)

P/L (Anual)

2.234

P/VP

1.8

P/S

22.38

Lucro por ação (EPS)

-3.137

Dividendo (TTM)

Rendimento de dividendos

0.00%

Ações em circulação

168.65M

Unidade monetária

USD

VIR Desempenho de Preço

7 dia

30 dia

90 dia

180 dia

No acumulado do ano

1 Ano

VIR Distribuição do fluxo de dinheiro

VIR Volume diário de venda a descoberto

VIR Histórico de short interest

VIR Visão geral da ação

As of 2026-07-28, the Vir Biotechnology, Inc. (VIR) stock price today is 8.8. Based on this price, the company has a market capitalization of $1.46B, with a P/E ratio of --. On 2026-07-28, VIR traded between 8.77 and 9.09. Today’s stock price is 0.34% above the daily low and 3.19% below the daily high, placing VIR perto da faixa inferior de its most recent trading range. Trading volume currently stands at 1.68M, compared with an average daily volume of 1.65M. This suggests that trading activity is aproximadamente em linha com o nível habitual than usual. Over the past year, Vir Biotechnology, Inc. shares have traded between 4.16 and 11.66. At today’s price, VIR is 111.54% above its 52-week low and 24.53% below its 52-week high.

VIR Notícias relacionadas

Sobre VIR

Nome empresa

Vir Biotechnology, Inc.

Setor

Health Technology

Indústria

Biotechnology

Trocas

Nasdaq

Número de funcionários

367

Tamanho do lote

100

Site oficial

www.vir.bio

Unidade monetária

USD

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Related Stocks

VIR FAQ

1.What is the live stock price of Vir Biotechnology, Inc. (VIR) today?

3. What is the latest pre-market price of VIR?

5.How has VIR’s stock price performed recently?

7. What is the current capital flow for VIR?

9. What is the current price of NVDA stock perps?

11. What is the market capitalization of Vir Biotechnology, Inc.?

13. What is Vir Biotechnology, Inc.’s earnings per share (EPS)?

15. Does Vir Biotechnology, Inc. pay dividends?

17. How many employees does Vir Biotechnology, Inc. have?

2. What were VIR’s trading range and trading volume on the most recent trading day?

4.What is VIR’s after-hours price?

6. What are VIR’s 52-week high and 52-week low?

8. What are VIR’s short sale volume and short interest?

10. What are Vir Biotechnology, Inc.’s P/E ratio and valuation metrics?

12. What were Vir Biotechnology, Inc.’s revenue and net income in the most recent quarter?

14.What is Vir Biotechnology, Inc.’s total number of shares outstanding?

16. Which exchange is Vir Biotechnology, Inc. listed on, and what sector and industry does it belong to?

18. What risks should investors consider before investing in VIR?